Form 4: Integrated BioPharma CFO Exercises Stock Options, Acquires 135,000 Shares
SEC Form 4 Filing
Dina Masi, CFO of Integrated BioPharma Inc., acquired 135,000 shares of common stock by exercising stock options at $0.09 per share.
Summary
- On May 21, 2025, Dina Masi, the Chief Financial Officer of Integrated BioPharma Inc. (INBP), exercised stock options to acquire 135,000 shares of common stock.
- The exercise price was $0.09 per share.
- Following the transaction, Masi directly owns 347,200 shares of Integrated BioPharma Inc.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions. It provides transparency into the trading activities of company executives, which can be of interest to investors.
Key Dates
| Date | Description |
|---|---|
| 06/02/2015 | Date of stock option grant, with 72,500 options immediately exercisable and the remaining 62,500 becoming exercisable in three equal annual installments beginning on this date. |
| 05/21/2025 | Date of transaction: CFO Dina Masi exercised stock options to acquire 135,000 shares of common stock. |
| 05/22/2025 | Date of signature on the Form 4 filing. |
Keywords
stock options, Form 4, INBP, Integrated BioPharma, Dina Masi, CFO, beneficial ownership, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.